EP1631214B1 - Stent delivery system having improved securement means - Google Patents

Stent delivery system having improved securement means Download PDF

Info

Publication number
EP1631214B1
EP1631214B1 EP04750291A EP04750291A EP1631214B1 EP 1631214 B1 EP1631214 B1 EP 1631214B1 EP 04750291 A EP04750291 A EP 04750291A EP 04750291 A EP04750291 A EP 04750291A EP 1631214 B1 EP1631214 B1 EP 1631214B1
Authority
EP
European Patent Office
Prior art keywords
stent
catheter
flexible connecting
balloon
securement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP04750291A
Other languages
German (de)
French (fr)
Other versions
EP1631214A1 (en
Inventor
Daniel Gregorich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Ltd Barbados
Original Assignee
Boston Scientific Ltd Barbados
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Ltd Barbados filed Critical Boston Scientific Ltd Barbados
Publication of EP1631214A1 publication Critical patent/EP1631214A1/en
Application granted granted Critical
Publication of EP1631214B1 publication Critical patent/EP1631214B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30329Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2002/30428Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by inserting a protrusion into a slot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/828Means for connecting a plurality of stents allowing flexibility of the whole structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91591Locking connectors, e.g. using male-female connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9505Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • A61F2002/9583Means for holding the stent on the balloon, e.g. using protrusions, adhesives or an outer sleeve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped

Definitions

  • a stent is a generally cylindrical prosthesis introduced via a catheter into a lumen of a body vessel in a configuration having a generally reduced diameter, and then expanded to the diameter of the vessel. In its expanded configuration, the stent supports and reinforces the vessel walls while maintaining the vessel in an open, unobstructed condition.
  • Inflation expandable stents are crimped to their reduced diameter about the delivery catheter, maneuvered to the deployment site, and expanded to the vessel diameter by fluid inflation of a balloon positioned on the delivery catheter.
  • the present invention is particularly concerned with delivery and deployment of inflation expandable stents.
  • present stents commonly combine a thin wall thickness with high flexibility, which leads to various drawbacks associated with stent delivery.
  • Stents with a reduced wall thickness typically have reduced strength in all directions.
  • a stent with reduced strength has less ability to remain secure on the balloon and delivery catheter in the reduced state. Therefore, the stent has an increased risk of shifting positions on the catheter as it is maneuvered through the body.
  • the stent must be able to securely maintain its axial position on the delivery catheter without translocation of its proximal or distal ends.
  • Reducing stent wall thickness may also reduce the axial strength of the stent. Lowered axial rigidity allows the stent to more easily pass through curved bodily vessels but can also lead to difficulty in stent placement during expansion.
  • the stent When a stent with low axial rigidity is expanded by a balloon catheter, the stent may experience increased shortening or lengthening. If balloon inflation begins at the ends and continues inward, the deployed stent often has a shorter overall length after expansion. Conversely, if balloon inflation begins at the center and moves outwardly, the stent often experiences lengthening upon deployment.
  • Inflation expandable stent delivery and deployment assemblies are known which utilize restraining means that overlie the stent during delivery.
  • U. S. Pat. No. 4,950, 227 to Savin et al discusses an expandable stent delivery system in which a sleeve overlaps the distal or proximal margin (or both) of the stent during delivery. During expansion of the stent at the deployment site, the stent margins are freed of the protective sleeve(s).
  • U. S. Pat. No. 5,403, 341 to Solar relates to a stent delivery and deployment assembly which uses retaining sheaths positioned about opposite ends of the compressed stent.
  • the retaining sheaths of Solar are adapted to tear under pressure as the stent is radially expanded, thus releasing the stent from engagement with the sheaths.
  • U.S. Pat. No. 5, 108, 416 to Ryan et al. describes a stent introducer system which uses one or two flexible end caps and an annular socket surrounding the balloon to position the stent during introduction to the deployment site.
  • WO 98/07388 A1 discloses the features of the preamble of claim 1. It shows a stent delivery system to facilitate introduction placement of a stent, including a catheter having an expandable distal portion constructed and arranged for expanding the outer diameter of the catheter from a contracted state to an expanded state, a stent positioned around the distal portion of the catheter having a contracted condition and being expandable to an expanded condition, and being sized in the contracted condition to closely surround the catheter in a contracted state, the expandable distal portion of the catheter including a balloon within which there is included on a catheter shaft at least one body of a diameter larger than the catheter shaft to which the stent and balloon are fitted, for holding the stent in place until it is released therefrom by expansion of the balloon.
  • an implant delivery system with interlock which includes an elongated member having an implant mounting location.
  • a self-expandable implant is mounted at the implant mounting location.
  • the implant is held in a compressed orientation by a retractable sheath.
  • An interlock structure prevents the implant from deploying prematurely as the sheath is retracted.
  • the present invention is directed to a device for preventing stent movement during delivery.
  • the device includes a securement connector arranged to engage a catheter, at least one flexible connecting member and at least one locking member arranged to engage a portion of a stent.
  • the device is capable of constraining portions of the stent throughout expansion of the stent.
  • the present invention is directed to a stent delivery system including a catheter, an expandable balloon a radially expandable stent and at least one radially expandable constrainment member.
  • the constrainment member has a first end coupled to said catheter and a second end having at least one portion arranged to engage the stent. The constrainment member may remain engaged with the stent throughout expansion of the balloon.
  • the present invention is directed to a stent delivery system including a catheter, an expandable balloon a radially expandable stent and at least one radially expandable constrainment member.
  • the constrainment member generally comprises a circumferential band having a plurality of openings therethrough and at least one engaging portion.
  • the constrainment member is arranged to at least partially overlay the balloon, and the at least on engaging portion is arranged to engage the stent.
  • the present invention is directed to a stent securement member 10 as depicted in Figs. 1 - 4 .
  • the securement member 10 generally comprises a securement connector 14, a flexible connecting member 18 and a locking or engaging member 22.
  • the securement member 10 may be used with a stent 28 having an engagable portion 30 desirably located at the one or both ends of the stent 28.
  • the locking member 22 is arranged to engage the stent engagable portion 30 and thereby constrain movement of the stent 28. Desirably, movement of the stent 28 at the stent engagable portion 30 will be constrained in two dimensions.
  • the securement member 10 will prevent movement in the stent axial direction, as well as preventing rotation of the stent 28 about the balloon. Desirably, the securement member 10 will not restrain movement in the direction of radial expansion of the stent 28.
  • the securement member 10 will typically be used during stent delivery in conjunction with a catheter 34 and an expansion balloon 36.
  • a balloon expandable stent 28 is typically crimped in a reduced state around a balloon 36 and catheter 34.
  • the securement member 10 may be placed upon the catheter 34 with the locking member 22 engaging the stent engagable portion 30.
  • the securement connector 14 may be coupled to the catheter 34 shaft, desirably by thermal bonding, adhesive bonding, swaging or by having a diameter of appropriate size to frictionally engage the catheter 34.
  • the securement connector 14 desirably encircles the catheter 34, the securement connector 14 may be of any size, shape or material that adequately engages the catheter 34.
  • the flexible connecting member 18 desirably overlays a portion of the expandable balloon 36 when the securement member 10 is in place.
  • the flexible connecting member 18 is desirably made from a shape memory material.
  • the shape memory material may be a metal such as NiTi, CuZnAl, CuAlNi, MP35N, Elgiloy, Phynox, TiPtNi, TiPdNi, Cu-Zn, Cu-Al, Fe-Cr-Ni, Fe-Pd or Fe-Pt.
  • the shape memory material may also be a polymer such as polymethylmethacrylate, polyvinylchloride, polynorbornene, trans-polyisoprene, polyurethane, styrene-butadiene copolymer or polyethylene. Further, the flexible connecting member 18 desirably will normally return to this reduced configuration.
  • the stent 28 upon expansion of the balloon 36, the stent 28 is expanded.
  • the flexible connecting member 18 is desirably sufficiently flexible and of sufficient length to allow displacement of the locking member 22 in a stent radial direction equal to the radial expansion of the stent 28.
  • the securement member 10 prevents movement of the stent engagable portion 30 in the axial direction, thereby preventing stent lengthening or foreshortening.
  • the securement member 10 will also constrain the stent engagable portion 30 from rotation about the balloon 36.
  • the balloon 36 is deflated.
  • the securement member 10 desirably returns to its original reduced configuration. Desirably, this is accomplished by pseudo-elastic effect of the flexible connecting member 18. Desirably, the temperature at which the Austenite phase of the shape memory alloy finishes forming is lower than human body temperature. Thus, throughout the entire time period that the securement member 10 remains in the body, the shape memory alloy will remain in the pseudo-elastic state.
  • the shape memory alloy may be deformed in the Martensitic state.
  • the flexible connecting member 18 may be returned to its original reduced configuration by introducing a heated fluid into the vessel.
  • the shape memory alloy desirably experiences a phase change and transforms to an Austenitic state upon introduction of the heated fluid.
  • the securement member 10 may additionally apply pressure to the balloon 36, resulting in faster deflation times.
  • the securement member locking member 22 becomes disengaged from the stent engagable portion 30.
  • the catheter 34, deflated balloon 36 and securement member 10 are free to move independently from the stent 28. Thus, the catheter 34, balloon 36 and securement member 10 may be removed from the patient.
  • the present invention is directed to a stent securement member 10 as depicted in Figs. 5 - 8 .
  • the securement member 10 generally comprises a securement connector 14, a plurality of flexible connecting members 18 and a plurality of locking or engaging members 22.
  • the flexible connecting members 18 may form a serpentine circumferential band.
  • the securement member 10 may be used with a stent 28 having a plurality of engagable portions 30 desirably located at one or both ends of the stent 28.
  • the locking members 22 are arranged to engage the stent engagable portions 30 and thereby constrain movement of the stent 28. Desirably, movement of the stent 28 at the stent engagable portions 30 will be constrained in two dimensions.
  • the securement member 10 will prevent movement in the stent axial direction, as well as preventing rotation of the stent 28 about the balloon. Desirably, the securement member 10 will not restrain movement in the direction of radial expansion of the stent 28.
  • the securement member 10 will typically be used during stent delivery in conjunction with a catheter 34 and an expansion balloon 36.
  • a balloon expandable stent 28 is typically crimped in a reduced state around a balloon 36 and catheter 34.
  • the securement member 10 may be placed upon the catheter 34 with the locking members 22 engaging the stent engagable portions 30 appropriately.
  • the securement connector 14 may be coupled to the catheter 34 shaft, desirably by swaging or by having a diameter of appropriate size to frictionally engage the catheter 34. Although the securement connector 14 desirably encircles the catheter 34, the securement connector 14 may be of any size, shape or material that adequately engages the catheter 34.
  • the flexible connecting members 18 desirably overlay a portion of the expandable balloon 36 when the securement member 10 is in place.
  • the flexible connecting members 18 are desirably made from a shape memory material, such as NiTi, CuZnAl, CuAlNi, MP35N, Elgiloy, Phynox, TiPtNi, TiPdNi, Cu-Zn, Cu-Al, Fe-Cr-Ni, Fe-Pd or Fe-Pt.
  • the shape memory material may also be a polymer such as polymethylmethacrylate, polyvinylchloride, polynorbornene, trans-polyisoprene, polyurethane, styrene-butadiene copolymer or polyethylene. Further, the flexible connecting members 18 desirably will normally return to this reduced configuration.
  • the flexible connecting members 18 are desirably sufficiently flexible and of sufficient length to allow displacement of the locking members 22 in a stent radial direction equal to the radial expansion of the stent 28.
  • the securement member 10 prevents movement of the stent engagable portion 30 in the axial direction, thereby preventing stent lengthening or foreshortening.
  • the securement member 10 will also constrain the stent engagable portion 30 from rotation about the balloon 36.
  • multiple locking members 22 help to accomplish a uniform and proportional circumferential expansion of the stent 28.
  • the balloon 36 is deflated.
  • the securement member 10 desirably returns to its original reduced configuration. Desirably, this is accomplished by pseudo-elastic effect of the flexible connecting members 18. Desirably, the temperature at which the Austenite phase of the shape memory alloy finishes forming is lower than human body temperature. Thus, throughout the entire time period that the securement member 10 remains in the body, the shape memory alloy will remain in the pseudo-elastic state.
  • the shape memory alloy may be deformed in the Martensitic state.
  • the flexible connecting member 18 may be returned to its original reduced configuration by introducing a heated fluid into the vessel.
  • the shape memory alloy desirably experiences a phase change and transforms to an Austenitic state upon introduction of the heated fluid.
  • the securement member 10 may additionally apply pressure to the balloon 36, resulting in faster deflation times. As the balloon 36 deflates, the securement member locking members 22 become disengaged from the stent engagable portions 30.
  • the catheter 34, deflated balloon 36 and securement member 10 are free to move independently from the stent 28. Thus, the catheter 34, balloon 36 and securement member 10 may be removed from the patient.
  • FIG. 9 -15 Further embodiments of the invention are depicted in Figs. 9 -15 .
  • Fig. 9 shows an embodiment of a securement member 10 comprising a securement connector 14, a plurality of flexible connecting members 18 and a plurality of locking or engaging members 22.
  • the flexible connecting members 18 form a serpentine circumferential band, and locking members 22 work in conjunction with each other to engage the stent engagable portion 30.
  • the stent engagable portion 30 in this embodiment may be a rounded peak at an end portion of the stent 28.
  • Fig. 10 shows an embodiment of a securement member 10 comprising a securement connector 14, a plurality of flexible connecting members 18 and at least one locking or engaging member 22.
  • the flexible connecting members 18 form a serpentine circumferential band, and locking members 22 are formed on a portion of the serpentine circumferential band peaks.
  • the stent engagable portion 30 in this embodiment may be a rounded peak at an end portion of the stent 28.
  • Fig. 11 shows an embodiment of a securement member 10 comprising a securement connector 14, a plurality of flexible connecting members 18 and at least one locking or engaging member 22.
  • the flexible connecting members 18 form a serpentine circumferential band, and locking members 22 are formed on a portion of the serpentine circumferential band peaks.
  • Fig. 12 shows an embodiment of a securement member 10 comprising a securement connector 14, a plurality of flexible connecting members. 18 and at least one locking or engaging member 22.
  • the flexible connecting members 18 form a serpentine circumferential band, and locking members 22 are formed on a portion of the serpentine circumferential band peaks.
  • the locking members 22 of this embodiment are designed to engage the stent engagable portion 30 to constrict motion in only the axial direction.
  • Fig. 13 shows another embodiment of a securement member 10.
  • Locking members 22 in this embodiment comprise an "I” or an "H” shape, and stent engagable portions 30 are suitably shaped to receive the locking members 22.
  • Fig. 14 shows another embodiment of a securement member 10.
  • Locking members 22 and stent engagable portions 30 comprise hooks in this embodiment.
  • Fig. 15 shows another embodiment of a securement member 10.
  • Locking members 22 in this embodiment further may include a radiopaque marker 38.
  • securement member 10 Although only one securement member 10 has been shown attached to a catheter in Figs. 1- 8 , it is within the purview of the invention to use multiple securement members 10 in conjunction with a single stent 28. Desirably, one securement member 10 will be used at each end of the stent 28, as depicted in Fig. 16 . Optionally a plurality of securement members may be used at one or both ends of the stent. Thus, for example, one end of the stent may be provided with two or more securement members.

Abstract

The present invention comprises a securement member to improve securement of a stent upon an expandable balloon and delivery catheter, and to constrain portions of the stent before and during stent deployment. Generally, the securement member comprises a securement connector arranged to engage a catheter, at least one flexible connecting member coupled to the securement connector, and a locking member arranged to engage a portion of a stent.

Description

    BACKGROUND OF THE INVENTION
  • Stents and stent delivery assemblies are utilized in a number of medical procedures and situations, and as such their structure and function are well known. A stent is a generally cylindrical prosthesis introduced via a catheter into a lumen of a body vessel in a configuration having a generally reduced diameter, and then expanded to the diameter of the vessel. In its expanded configuration, the stent supports and reinforces the vessel walls while maintaining the vessel in an open, unobstructed condition.
  • Both self-expanding and inflation expandable stents are well known and widely available in a variety of designs and configurations. Inflation expandable stents are crimped to their reduced diameter about the delivery catheter, maneuvered to the deployment site, and expanded to the vessel diameter by fluid inflation of a balloon positioned on the delivery catheter. The present invention is particularly concerned with delivery and deployment of inflation expandable stents.
  • There is currently a drive in the market to reduce the wall thickness of expandable coronary stents. Clinical results have shown that a reduced stent wall thickness improves vascular response.
  • There is also a market drive to make stents more flexible, allowing physicians to more easily maneuver stents through the bodily lumen, especially through the tortuous paths common in small vessels.
  • Thus, present stents commonly combine a thin wall thickness with high flexibility, which leads to various drawbacks associated with stent delivery. Stents with a reduced wall thickness typically have reduced strength in all directions. A stent with reduced strength has less ability to remain secure on the balloon and delivery catheter in the reduced state. Therefore, the stent has an increased risk of shifting positions on the catheter as it is maneuvered through the body. The stent must be able to securely maintain its axial position on the delivery catheter without translocation of its proximal or distal ends.
  • Reducing stent wall thickness may also reduce the axial strength of the stent. Lowered axial rigidity allows the stent to more easily pass through curved bodily vessels but can also lead to difficulty in stent placement during expansion.
  • When a stent with low axial rigidity is expanded by a balloon catheter, the stent may experience increased shortening or lengthening. If balloon inflation begins at the ends and continues inward, the deployed stent often has a shorter overall length after expansion. Conversely, if balloon inflation begins at the center and moves outwardly, the stent often experiences lengthening upon deployment.
  • Inflation expandable stent delivery and deployment assemblies are known which utilize restraining means that overlie the stent during delivery. U. S. Pat. No. 4,950, 227 to Savin et al discusses an expandable stent delivery system in which a sleeve overlaps the distal or proximal margin (or both) of the stent during delivery. During expansion of the stent at the deployment site, the stent margins are freed of the protective sleeve(s). U. S. Pat. No. 5,403, 341 to Solar relates to a stent delivery and deployment assembly which uses retaining sheaths positioned about opposite ends of the compressed stent. The retaining sheaths of Solar are adapted to tear under pressure as the stent is radially expanded, thus releasing the stent from engagement with the sheaths. U.S. Pat. No. 5, 108, 416 to Ryan et al. describes a stent introducer system which uses one or two flexible end caps and an annular socket surrounding the balloon to position the stent during introduction to the deployment site.
  • WO 98/07388 A1 discloses the features of the preamble of claim 1. It shows a stent delivery system to facilitate introduction placement of a stent, including a catheter having an expandable distal portion constructed and arranged for expanding the outer diameter of the catheter from a contracted state to an expanded state, a stent positioned around the distal portion of the catheter having a contracted condition and being expandable to an expanded condition, and being sized in the contracted condition to closely surround the catheter in a contracted state, the expandable distal portion of the catheter including a balloon within which there is included on a catheter shaft at least one body of a diameter larger than the catheter shaft to which the stent and balloon are fitted, for holding the stent in place until it is released therefrom by expansion of the balloon.
  • Further, from WO 02/067782 A2 an implant delivery system with interlock is disclosed which includes an elongated member having an implant mounting location. A self-expandable implant is mounted at the implant mounting location. The implant is held in a compressed orientation by a retractable sheath. An interlock structure prevents the implant from deploying prematurely as the sheath is retracted.
  • These known methods typically release the stent early in the balloon inflation procedure and do not maintain the axial dimensions of the stent during inflation.
  • There remains a need for stent delivery systems that constrain the axial dimensions of the stent until the stent is fully expanded.
  • Without limiting the scope of the invention a brief summary of some of the claimed embodiments of the invention is set forth below. Additional details of the summarized embodiments of the invention and/or additional embodiments of the invention may be found in the Detailed Description of the Invention below.
  • A brief abstract of the technical disclosure in the specification is provided. The abstract is not intended to be used for interpreting the scope of the claims.
  • BRIEF SUMMARY OF THE INVENTION
  • In one embodiment, the present invention is directed to a device for preventing stent movement during delivery. The device includes a securement connector arranged to engage a catheter, at least one flexible connecting member and at least one locking member arranged to engage a portion of a stent. The device is capable of constraining portions of the stent throughout expansion of the stent.
  • In another embodiment, the present invention is directed to a stent delivery system including a catheter, an expandable balloon a radially expandable stent and at least one radially expandable constrainment member. The constrainment member has a first end coupled to said catheter and a second end having at least one portion arranged to engage the stent. The constrainment member may remain engaged with the stent throughout expansion of the balloon.
  • In another embodiment, the present invention is directed to a stent delivery system including a catheter, an expandable balloon a radially expandable stent and at least one radially expandable constrainment member. The constrainment member generally comprises a circumferential band having a plurality of openings therethrough and at least one engaging portion. The constrainment member is arranged to at least partially overlay the balloon, and the at least on engaging portion is arranged to engage the stent. When the constrainment member and the stent are engaged, movement of the stent in the axial direction is prevented.
  • These and other embodiments which characterize the invention are pointed out with particularity in the claims annexed hereto and forming a part hereof. However, for a better understanding of the invention, its advantages and objectives obtained by its use, reference should be made to the drawings which form a further part hereof and the accompanying descriptive matter, in which there is illustrated and described a embodiments of the invention.
  • BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS
  • A detailed description of the invention is hereafter described with specific reference being made to the drawings.
    • FIG. 1 is a perspective view of an embodiment of an inventive stent securement member.
    • FIG. 2 is a perspective view of an embodiment of an inventive stent securement member placed on a catheter with a stent in the reduced state.
    • FIG. 3 is a perspective view of an embodiment of an inventive stent securement member placed on a catheter with a stent, wherein the expansion balloon is expanded.
    • FIG. 4 is a perspective view of an embodiment of an inventive stent securement member placed on a catheter after deflation of the balloon.
    • FIG. 5 is a perspective view of an embodiment of an inventive stent securement member.
    • FIG. 6 is a perspective view of an embodiment of an inventive stent securement member placed on a catheter with a stent in the reduced state.
    • FIG. 7 is a perspective view of an embodiment of an inventive stent securement member placed on a catheter with a stent, wherein the expansion balloon is expanded.
    • FIG. 8 is a perspective view of an embodiment of an inventive stent securement member placed on a catheter after deflation of the balloon.
    • FIG. 9 shows another embodiment of an inventive stent securement member.
    • FIG. 10 shows another embodiment of an inventive stent securement member.
    • FIG. 11 shows another embodiment of an inventive stent securement member.
    • FIG. 12 shows another embodiment of an inventive stent securement member.
    • FIG. 13 shows another embodiment of an inventive stent securement member.
    • FIG. 14 shows another embodiment of an inventive stent securement member.
    • FIG. 15 shows another embodiment of an inventive stent securement member having a radiopaque marker.
    • FIG. 16 is a perspective view of an embodiment of inventive stent securement members placed on a catheter with a stent in the reduced state.
    DETAILED DESCRIPTION OF THE INVENTION
  • While this invention may be embodied in many different forms, there are described in detail herein specific preferred embodiments of the invention. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
  • For the purposes of this disclosure, like reference numerals in the figures shall refer to like features unless otherwise indicated.
  • In one embodiment, the present invention is directed to a stent securement member 10 as depicted in Figs. 1 - 4. The securement member 10 generally comprises a securement connector 14, a flexible connecting member 18 and a locking or engaging member 22.
  • The securement member 10 may be used with a stent 28 having an engagable portion 30 desirably located at the one or both ends of the stent 28. The locking member 22 is arranged to engage the stent engagable portion 30 and thereby constrain movement of the stent 28. Desirably, movement of the stent 28 at the stent engagable portion 30 will be constrained in two dimensions. The securement member 10 will prevent movement in the stent axial direction, as well as preventing rotation of the stent 28 about the balloon. Desirably, the securement member 10 will not restrain movement in the direction of radial expansion of the stent 28.
  • The securement member 10 will typically be used during stent delivery in conjunction with a catheter 34 and an expansion balloon 36. A balloon expandable stent 28 is typically crimped in a reduced state around a balloon 36 and catheter 34. The securement member 10 may be placed upon the catheter 34 with the locking member 22 engaging the stent engagable portion 30. The securement connector 14 may be coupled to the catheter 34 shaft, desirably by thermal bonding, adhesive bonding, swaging or by having a diameter of appropriate size to frictionally engage the catheter 34. Although the securement connector 14 desirably encircles the catheter 34, the securement connector 14 may be of any size, shape or material that adequately engages the catheter 34. The flexible connecting member 18 desirably overlays a portion of the expandable balloon 36 when the securement member 10 is in place.
  • The flexible connecting member 18 is desirably made from a shape memory material. The shape memory material may be a metal such as NiTi, CuZnAl, CuAlNi, MP35N, Elgiloy, Phynox, TiPtNi, TiPdNi, Cu-Zn, Cu-Al, Fe-Cr-Ni, Fe-Pd or Fe-Pt. The shape memory material may also be a polymer such as polymethylmethacrylate, polyvinylchloride, polynorbornene, trans-polyisoprene, polyurethane, styrene-butadiene copolymer or polyethylene. Further, the flexible connecting member 18 desirably will normally return to this reduced configuration.
  • Referring to Figs. 3 and 4, upon expansion of the balloon 36, the stent 28 is expanded. The flexible connecting member 18 is desirably sufficiently flexible and of sufficient length to allow displacement of the locking member 22 in a stent radial direction equal to the radial expansion of the stent 28. During expansion, the securement member 10 prevents movement of the stent engagable portion 30 in the axial direction, thereby preventing stent lengthening or foreshortening. Desirably, the securement member 10 will also constrain the stent engagable portion 30 from rotation about the balloon 36.
  • When the stent 28 has reached the full deployment diameter, the balloon 36 is deflated. Upon deflation, the securement member 10 desirably returns to its original reduced configuration. Desirably, this is accomplished by pseudo-elastic effect of the flexible connecting member 18. Desirably, the temperature at which the Austenite phase of the shape memory alloy finishes forming is lower than human body temperature. Thus, throughout the entire time period that the securement member 10 remains in the body, the shape memory alloy will remain in the pseudo-elastic state.
  • Alternatively, the shape memory alloy may be deformed in the Martensitic state. The flexible connecting member 18 may be returned to its original reduced configuration by introducing a heated fluid into the vessel. The shape memory alloy desirably experiences a phase change and transforms to an Austenitic state upon introduction of the heated fluid.
  • During deflation of the balloon 36, the securement member 10 may additionally apply pressure to the balloon 36, resulting in faster deflation times. As the balloon 36 deflates, the securement member locking member 22 becomes disengaged from the stent engagable portion 30.
  • Upon proper deflation of the balloon 36, the catheter 34, deflated balloon 36 and securement member 10 are free to move independently from the stent 28. Thus, the catheter 34, balloon 36 and securement member 10 may be removed from the patient.
  • In another embodiment, the present invention is directed to a stent securement member 10 as depicted in Figs. 5 - 8. The securement member 10 generally comprises a securement connector 14, a plurality of flexible connecting members 18 and a plurality of locking or engaging members 22. The flexible connecting members 18 may form a serpentine circumferential band.
  • The securement member 10 may be used with a stent 28 having a plurality of engagable portions 30 desirably located at one or both ends of the stent 28. The locking members 22 are arranged to engage the stent engagable portions 30 and thereby constrain movement of the stent 28. Desirably, movement of the stent 28 at the stent engagable portions 30 will be constrained in two dimensions. The securement member 10 will prevent movement in the stent axial direction, as well as preventing rotation of the stent 28 about the balloon. Desirably, the securement member 10 will not restrain movement in the direction of radial expansion of the stent 28.
  • The securement member 10 will typically be used during stent delivery in conjunction with a catheter 34 and an expansion balloon 36. A balloon expandable stent 28 is typically crimped in a reduced state around a balloon 36 and catheter 34. The securement member 10 may be placed upon the catheter 34 with the locking members 22 engaging the stent engagable portions 30 appropriately. The securement connector 14 may be coupled to the catheter 34 shaft, desirably by swaging or by having a diameter of appropriate size to frictionally engage the catheter 34. Although the securement connector 14 desirably encircles the catheter 34, the securement connector 14 may be of any size, shape or material that adequately engages the catheter 34. The flexible connecting members 18 desirably overlay a portion of the expandable balloon 36 when the securement member 10 is in place.
  • The flexible connecting members 18 are desirably made from a shape memory material, such as NiTi, CuZnAl, CuAlNi, MP35N, Elgiloy, Phynox, TiPtNi, TiPdNi, Cu-Zn, Cu-Al, Fe-Cr-Ni, Fe-Pd or Fe-Pt. The shape memory material may also be a polymer such as polymethylmethacrylate, polyvinylchloride, polynorbornene, trans-polyisoprene, polyurethane, styrene-butadiene copolymer or polyethylene. Further, the flexible connecting members 18 desirably will normally return to this reduced configuration.
  • Referring to Figs. 7 and 8, upon expansion of the balloon 36, the stent 28 becomes expanded. The flexible connecting members 18 are desirably sufficiently flexible and of sufficient length to allow displacement of the locking members 22 in a stent radial direction equal to the radial expansion of the stent 28. During expansion, the securement member 10 prevents movement of the stent engagable portion 30 in the axial direction, thereby preventing stent lengthening or foreshortening. Desirably, the securement member 10 will also constrain the stent engagable portion 30 from rotation about the balloon 36. Further, multiple locking members 22 help to accomplish a uniform and proportional circumferential expansion of the stent 28.
  • When the stent 28 has reached the full deployment diameter, the balloon 36 is deflated. Upon deflation, the securement member 10 desirably returns to its original reduced configuration. Desirably, this is accomplished by pseudo-elastic effect of the flexible connecting members 18. Desirably, the temperature at which the Austenite phase of the shape memory alloy finishes forming is lower than human body temperature. Thus, throughout the entire time period that the securement member 10 remains in the body, the shape memory alloy will remain in the pseudo-elastic state.
  • Alternatively, the shape memory alloy may be deformed in the Martensitic state. The flexible connecting member 18 may be returned to its original reduced configuration by introducing a heated fluid into the vessel. The shape memory alloy desirably experiences a phase change and transforms to an Austenitic state upon introduction of the heated fluid.
  • During deflation of the balloon 36, the securement member 10 may additionally apply pressure to the balloon 36, resulting in faster deflation times. As the balloon 36 deflates, the securement member locking members 22 become disengaged from the stent engagable portions 30.
  • Upon proper deflation of the balloon 36, the catheter 34, deflated balloon 36 and securement member 10 are free to move independently from the stent 28. Thus, the catheter 34, balloon 36 and securement member 10 may be removed from the patient.
  • Further embodiments of the invention are depicted in Figs. 9 -15.
  • Fig. 9 shows an embodiment of a securement member 10 comprising a securement connector 14, a plurality of flexible connecting members 18 and a plurality of locking or engaging members 22. The flexible connecting members 18 form a serpentine circumferential band, and locking members 22 work in conjunction with each other to engage the stent engagable portion 30. Further, the stent engagable portion 30 in this embodiment may be a rounded peak at an end portion of the stent 28.
  • Fig. 10 shows an embodiment of a securement member 10 comprising a securement connector 14, a plurality of flexible connecting members 18 and at least one locking or engaging member 22. The flexible connecting members 18 form a serpentine circumferential band, and locking members 22 are formed on a portion of the serpentine circumferential band peaks. The stent engagable portion 30 in this embodiment may be a rounded peak at an end portion of the stent 28.
  • Fig. 11 shows an embodiment of a securement member 10 comprising a securement connector 14, a plurality of flexible connecting members 18 and at least one locking or engaging member 22. The flexible connecting members 18 form a serpentine circumferential band, and locking members 22 are formed on a portion of the serpentine circumferential band peaks.
  • Fig. 12 shows an embodiment of a securement member 10 comprising a securement connector 14, a plurality of flexible connecting members. 18 and at least one locking or engaging member 22. The flexible connecting members 18 form a serpentine circumferential band, and locking members 22 are formed on a portion of the serpentine circumferential band peaks. The locking members 22 of this embodiment are designed to engage the stent engagable portion 30 to constrict motion in only the axial direction.
  • Fig. 13 shows another embodiment of a securement member 10. Locking members 22 in this embodiment comprise an "I" or an "H" shape, and stent engagable portions 30 are suitably shaped to receive the locking members 22.
  • Fig. 14 shows another embodiment of a securement member 10. Locking members 22 and stent engagable portions 30 comprise hooks in this embodiment.
  • Fig. 15 shows another embodiment of a securement member 10. Locking members 22 in this embodiment further may include a radiopaque marker 38.
  • Although only one securement member 10 has been shown attached to a catheter in Figs. 1- 8, it is within the purview of the invention to use multiple securement members 10 in conjunction with a single stent 28. Desirably, one securement member 10 will be used at each end of the stent 28, as depicted in Fig. 16. Optionally a plurality of securement members may be used at one or both ends of the stent. Thus, for example, one end of the stent may be provided with two or more securement members.
  • The above disclosure is intended to be illustrative and not exhaustive. This description will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the claims where the term "comprising" means "including, but not limited to".
  • This completes the description of the various embodiments of the invention. Those skilled in the art may recognize other equivalents to the specific embodiment described herein which equivalents are intended to be encompassed by the claims attached hereto.

Claims (9)

  1. A device for preventing stent movement during delivery comprising:
    • a securement connector (14) arranged to engage a catheter;
    • at least one flexible connecting member (18) made from a shape memory material, said flexible connecting member (18) having a first end portion and a second end portion, the first end portion coupled to said securement connector (14); and
    • a locking member (22) located at said flexible connecting member (18) second end portion arranged to engage a portion of a stent (28),
    characterized in that the flexible connecting member (18) is sufficiently flexible and of sufficient length to allow displacement of the locking member (22) in a stent radial direction equal to the radial expansion of the stent (28).
  2. The device of claim 1, further comprising a plurality of flexible connecting members (18).
  3. The device of claim 2, wherein said flexible connecting members (18) are arranged to expand with the stent (28).
  4. The device of claim 2, wherein the flexible connecting members (18) form a serpentine circumferential band.
  5. The device of claim 1, wherein the flexible connecting member (18) is balloon expandable.
  6. The device of claim 5, wherein the shape memory material has an Af temperature lower than normal human body temperature.
  7. In combination, the device of claim 1 and a catheter (34), the catheter (34) having a balloon (36) with a stent (28) disposed thereabout, the stent (28) engaged to the device.
  8. The combination of claim 7 wherein the stent (28) includes an engagable portion (30) arranged to engage said locking member (22).
  9. The combination of claim 8 wherein the device is made of a shape memory material which is balloon expandable and which is programmed to return to an unexpanded diameter following balloon expansion.
EP04750291A 2003-05-20 2004-04-16 Stent delivery system having improved securement means Expired - Lifetime EP1631214B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/441,666 US7235093B2 (en) 2003-05-20 2003-05-20 Mechanism to improve stent securement
PCT/US2004/011951 WO2004103217A1 (en) 2003-05-20 2004-04-16 Stent delivery system having improved securement means

Publications (2)

Publication Number Publication Date
EP1631214A1 EP1631214A1 (en) 2006-03-08
EP1631214B1 true EP1631214B1 (en) 2009-06-17

Family

ID=33450043

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04750291A Expired - Lifetime EP1631214B1 (en) 2003-05-20 2004-04-16 Stent delivery system having improved securement means

Country Status (8)

Country Link
US (1) US7235093B2 (en)
EP (1) EP1631214B1 (en)
JP (1) JP4740861B2 (en)
AT (1) ATE433733T1 (en)
CA (1) CA2523259C (en)
DE (1) DE602004021593D1 (en)
ES (1) ES2328694T3 (en)
WO (1) WO2004103217A1 (en)

Families Citing this family (175)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858034B1 (en) * 1999-05-20 2005-02-22 Scimed Life Systems, Inc. Stent delivery system for prevention of kinking, and method of loading and using same
AU2001285078A1 (en) 2000-08-18 2002-03-04 Atritech, Inc. Expandable implant devices for filtering blood flow from atrial appendages
US7169172B2 (en) * 2002-11-01 2007-01-30 Counter Clockwise, Inc. Method and apparatus for caged stent delivery
US8449594B2 (en) 2002-11-01 2013-05-28 Marc-Alan Levine Method and apparatus for caged stent delivery
US6814746B2 (en) * 2002-11-01 2004-11-09 Ev3 Peripheral, Inc. Implant delivery system with marker interlock
US7972372B2 (en) 2003-04-14 2011-07-05 Tryton Medical, Inc. Kit for treating vascular bifurcations
US8083791B2 (en) 2003-04-14 2011-12-27 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7731747B2 (en) 2003-04-14 2010-06-08 Tryton Medical, Inc. Vascular bifurcation prosthesis with multiple thin fronds
US7758630B2 (en) 2003-04-14 2010-07-20 Tryton Medical, Inc. Helical ostium support for treating vascular bifurcations
US7717953B2 (en) 2004-10-13 2010-05-18 Tryton Medical, Inc. Delivery system for placement of prosthesis at luminal OS
US8109987B2 (en) 2003-04-14 2012-02-07 Tryton Medical, Inc. Method of treating a lumenal bifurcation
DE10325678A1 (en) * 2003-06-02 2004-12-23 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Connection system for connecting a stent to a radio-opaque marker and method for establishing a connection between a stent and two or more radio-opaque markers
US20050038497A1 (en) * 2003-08-11 2005-02-17 Scimed Life Systems, Inc. Deformation medical device without material deformation
US20050060025A1 (en) * 2003-09-12 2005-03-17 Mackiewicz David A. Radiopaque markers for medical devices
US20050137694A1 (en) 2003-12-23 2005-06-23 Haug Ulrich R. Methods and apparatus for endovascularly replacing a patient's heart valve
US7824443B2 (en) * 2003-12-23 2010-11-02 Sadra Medical, Inc. Medical implant delivery and deployment tool
US7959666B2 (en) * 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US11278398B2 (en) 2003-12-23 2022-03-22 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US7780725B2 (en) 2004-06-16 2010-08-24 Sadra Medical, Inc. Everting heart valve
US7748389B2 (en) 2003-12-23 2010-07-06 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US7329279B2 (en) 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8287584B2 (en) 2005-11-14 2012-10-16 Sadra Medical, Inc. Medical implant deployment tool
US8579962B2 (en) 2003-12-23 2013-11-12 Sadra Medical, Inc. Methods and apparatus for performing valvuloplasty
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
CN100589779C (en) 2003-12-23 2010-02-17 萨德拉医学公司 Repositionable heart valve
US8828078B2 (en) 2003-12-23 2014-09-09 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US7381219B2 (en) 2003-12-23 2008-06-03 Sadra Medical, Inc. Low profile heart valve and delivery system
US7445631B2 (en) 2003-12-23 2008-11-04 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US20050137687A1 (en) 2003-12-23 2005-06-23 Sadra Medical Heart valve anchor and method
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US7824442B2 (en) 2003-12-23 2010-11-02 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US9005273B2 (en) 2003-12-23 2015-04-14 Sadra Medical, Inc. Assessing the location and performance of replacement heart valves
US20120041550A1 (en) 2003-12-23 2012-02-16 Sadra Medical, Inc. Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements
US8568469B1 (en) * 2004-06-28 2013-10-29 Advanced Cardiovascular Systems, Inc. Stent locking element and a method of securing a stent on a delivery system
US7744641B2 (en) * 2004-07-21 2010-06-29 Boston Scientific Scimed, Inc. Expandable framework with overlapping connectors
US7323008B2 (en) * 2004-08-09 2008-01-29 Medtronic Vascular, Inc. Flexible stent
US9283099B2 (en) 2004-08-25 2016-03-15 Advanced Cardiovascular Systems, Inc. Stent-catheter assembly with a releasable connection for stent retention
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US20060252983A1 (en) * 2005-02-11 2006-11-09 Lembo Nicholas J Dynamically adjustable gastric implants and methods of treating obesity using dynamically adjustable gastric implants
US8002818B2 (en) * 2005-02-25 2011-08-23 Abbott Laboratories Vascular Enterprises Limited Modular vascular prosthesis having axially variable properties and improved flexibility and methods of use
US8025694B2 (en) 2005-02-25 2011-09-27 Abbott Laboratories Vascular Enterprises Limited Modular vascular prosthesis and methods of use
US7962208B2 (en) 2005-04-25 2011-06-14 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
EP1903999B1 (en) * 2005-04-25 2018-11-21 Covidien LP Controlled fracture connections for stents
EP3266414A1 (en) 2005-05-12 2018-01-10 Covidien LP Implant delivery system with interlocked rx port orientation
US7712606B2 (en) 2005-09-13 2010-05-11 Sadra Medical, Inc. Two-part package for medical implant
DE102005053393A1 (en) 2005-11-09 2007-05-10 Biotronik Vi Patent Ag Application system for a stent
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
EP1988851A2 (en) 2006-02-14 2008-11-12 Sadra Medical, Inc. Systems and methods for delivering a medical implant
US8652192B2 (en) * 2006-03-31 2014-02-18 St. Jude Medical, Cardiology Division, Inc. Stent and system and method for deploying a stent
US9615832B2 (en) * 2006-04-07 2017-04-11 Penumbra, Inc. Aneurysm occlusion system and method
US8690935B2 (en) 2006-04-28 2014-04-08 DePuy Synthes Products, LLC Stent delivery system with threaded engagement and method
EP2353553B1 (en) * 2006-05-12 2015-12-02 Covidien LP Implant and delivery system with multiple marker interlocks
US20070288081A1 (en) * 2006-05-18 2007-12-13 Abbott Laboratories Stent delivery system having a stent stopper
US20080004696A1 (en) * 2006-06-29 2008-01-03 Valvexchange Inc. Cardiovascular valve assembly with resizable docking station
US8460364B2 (en) * 2006-07-20 2013-06-11 Orbusneich Medical, Inc. Bioabsorbable polymeric medical device
AU2007281553B2 (en) 2006-07-31 2013-09-19 Edwards Lifesciences Cardiaq Llc Sealable endovascular implants and methods for their use
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US8323325B2 (en) * 2006-09-25 2012-12-04 Boston Scientific Scimed, Inc. Balloon with wings for rotational stent
CA2764601A1 (en) * 2006-10-23 2008-05-02 Valvexchange Inc. Cardiovascular valve and assembly
DE102007015670A1 (en) * 2007-03-31 2008-10-02 Biotronik Vi Patent Ag Stent with radially expandable body
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US9566178B2 (en) * 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
WO2011104269A1 (en) 2008-02-26 2011-09-01 Jenavalve Technology Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
US20090306760A1 (en) * 2008-06-06 2009-12-10 Bay Street Medical Prosthesis and delivery system
EP2147663A1 (en) 2008-07-23 2010-01-27 Abbott Laboratories Vascular Enterprises Limited Stent movement preventing device
EP2331015A1 (en) * 2008-09-12 2011-06-15 ValveXchange Inc. Valve assembly with exchangeable valve member and a tool set for exchanging the valve member
CN102245256B (en) * 2008-10-10 2014-07-23 萨德拉医学公司 Medical devices and delivery systems for delivering medical devices
WO2010077676A1 (en) * 2008-12-08 2010-07-08 Elmaleh David R Delivery system for intravascular device with netting
US8114112B2 (en) * 2008-12-30 2012-02-14 Cook Medical Technologies Llc Stylet locking mechanism for medical delivery devices
DE102009021039B3 (en) * 2009-05-13 2010-11-25 Acandis Gmbh & Co. Kg Medical device for release in a hollow organ and medical device import system
US8858613B2 (en) 2010-09-20 2014-10-14 Altura Medical, Inc. Stent graft delivery systems and associated methods
US8382818B2 (en) 2009-07-02 2013-02-26 Tryton Medical, Inc. Ostium support for treating vascular bifurcations
CA2782385A1 (en) 2009-12-01 2011-06-09 Altura Medical, Inc. Modular endograft devices and associated systems and methods
CN102740800A (en) * 2010-01-29 2012-10-17 爱尔康医药有限公司 Biodegradable protrusions on inflatable device
TWI537314B (en) * 2010-04-08 2016-06-11 國立清華大學 Micro-fluidic power system and a method to produce the same
EP2560589B1 (en) * 2010-04-23 2018-06-06 Medtronic, Inc. Delivery systems for prosthetic heart valves
JP5803010B2 (en) * 2010-04-27 2015-11-04 メドトロニック,インコーポレイテッド Transcatheter prosthetic heart valve delivery device with deflection release characteristics
JP2013526388A (en) 2010-05-25 2013-06-24 イエナバルブ テクノロジー インク Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent
US9387077B2 (en) * 2010-05-27 2016-07-12 Medtronic Vascular Galway Catheter assembly with prosthesis crimping and prosthesis retaining accessories
AU2011279727B2 (en) * 2010-07-15 2014-03-27 St. Jude Medical, Inc. Retainers for transcatheter heart valve delivery systems
WO2012023980A1 (en) 2010-08-17 2012-02-23 St. Jude Medical, Inc. Sleeve for facilitating movement of a transfemoral catheter
CN106073946B (en) 2010-09-10 2022-01-04 西美蒂斯股份公司 Valve replacement device, delivery device for a valve replacement device and method of producing a valve replacement device
BR112013006302A2 (en) 2010-09-17 2016-06-07 St Jude Medical Cardiology Div placement device for a collapsible prosthetic heart valve, and method for placing a collapsible prosthetic heart valve
US9468547B2 (en) 2010-11-11 2016-10-18 W. L. Gore & Associates, Inc. Deployment of endoluminal devices
US9707108B2 (en) 2010-11-24 2017-07-18 Tryton Medical, Inc. Support for treating vascular bifurcations
EP2688516B1 (en) 2011-03-21 2022-08-17 Cephea Valve Technologies, Inc. Disk-based valve apparatus
EP2520251A1 (en) 2011-05-05 2012-11-07 Symetis SA Method and Apparatus for Compressing Stent-Valves
CA2835893C (en) 2011-07-12 2019-03-19 Boston Scientific Scimed, Inc. Coupling system for medical devices
EP2736450A1 (en) 2011-07-28 2014-06-04 St. Jude Medical, Inc. Expandable radiopaque marker for transcatheter aortic valve implantation
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9131926B2 (en) 2011-11-10 2015-09-15 Boston Scientific Scimed, Inc. Direct connect flush system
US8940014B2 (en) 2011-11-15 2015-01-27 Boston Scientific Scimed, Inc. Bond between components of a medical device
US8951243B2 (en) 2011-12-03 2015-02-10 Boston Scientific Scimed, Inc. Medical device handle
US9510945B2 (en) 2011-12-20 2016-12-06 Boston Scientific Scimed Inc. Medical device handle
US9277993B2 (en) 2011-12-20 2016-03-08 Boston Scientific Scimed, Inc. Medical device delivery systems
US10172708B2 (en) 2012-01-25 2019-01-08 Boston Scientific Scimed, Inc. Valve assembly with a bioabsorbable gasket and a replaceable valve implant
US10028854B2 (en) * 2012-02-02 2018-07-24 Covidien Lp Stent retaining systems
CA2865013C (en) 2012-02-22 2020-12-15 Syntheon Cardiology, Llc Actively controllable stent, stent graft, heart valve and method of controlling same
EP2841024B1 (en) 2012-04-26 2017-05-03 Tryton Medical, Inc. Support for treating vascular bifurcations
US9883941B2 (en) 2012-06-19 2018-02-06 Boston Scientific Scimed, Inc. Replacement heart valve
US9480561B2 (en) 2012-06-26 2016-11-01 St. Jude Medical, Cardiology Division, Inc. Apparatus and method for aortic protection and TAVI planar alignment
US9918837B2 (en) 2012-06-29 2018-03-20 St. Jude Medical, Cardiology Division, Inc. System to assist in the release of a collapsible stent from a delivery device
US10285833B2 (en) 2012-08-10 2019-05-14 Lombard Medical Limited Stent delivery systems and associated methods
WO2014062713A1 (en) 2012-10-15 2014-04-24 Elmaleh David R Material structures for intravascular device
EP3545915A1 (en) * 2013-02-28 2019-10-02 Boston Scientific Scimed Inc. Implantable medical devices for reduced tissue inflammation
US10561509B2 (en) 2013-03-13 2020-02-18 DePuy Synthes Products, Inc. Braided stent with expansion ring and method of delivery
US9737426B2 (en) 2013-03-15 2017-08-22 Altura Medical, Inc. Endograft device delivery systems and associated methods
US8870948B1 (en) 2013-07-17 2014-10-28 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
CN105491978A (en) 2013-08-30 2016-04-13 耶拿阀门科技股份有限公司 Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
DE102013014523A1 (en) * 2013-09-03 2015-03-05 Phenox Gmbh Insertion and detachment system for implants
EP3043755B1 (en) 2013-09-12 2022-10-19 St. Jude Medical, Cardiology Division, Inc. Atraumatic interface in an implant delivery device
JP2017086095A (en) * 2014-03-17 2017-05-25 テルモ株式会社 Indwelling object delivery system
ES2684405T3 (en) * 2014-04-08 2018-10-02 Stryker Corporation Implant delivery system
WO2015195263A1 (en) * 2014-06-20 2015-12-23 Ethicon Endo-Surgery, Inc. Artificial esophageal sphincter
EP2957267B1 (en) * 2014-06-20 2017-09-27 Ethicon LLC Artificial sphincter
US10206796B2 (en) 2014-08-27 2019-02-19 DePuy Synthes Products, Inc. Multi-strand implant with enhanced radiopacity
US9901445B2 (en) 2014-11-21 2018-02-27 Boston Scientific Scimed, Inc. Valve locking mechanism
US9439757B2 (en) 2014-12-09 2016-09-13 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
WO2016115375A1 (en) 2015-01-16 2016-07-21 Boston Scientific Scimed, Inc. Displacement based lock and release mechanism
US9861477B2 (en) 2015-01-26 2018-01-09 Boston Scientific Scimed Inc. Prosthetic heart valve square leaflet-leaflet stitch
JP2018507018A (en) 2015-01-28 2018-03-15 エイオールティック イノベーションズ エルエルシーAortic Innovations Llc Modular intra-aortic device and method of use
US9788942B2 (en) 2015-02-03 2017-10-17 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
WO2016126524A1 (en) 2015-02-03 2016-08-11 Boston Scientific Scimed, Inc. Prosthetic heart valve having tubular seal
US10285809B2 (en) 2015-03-06 2019-05-14 Boston Scientific Scimed Inc. TAVI anchoring assist device
US10426617B2 (en) 2015-03-06 2019-10-01 Boston Scientific Scimed, Inc. Low profile valve locking mechanism and commissure assembly
US10080652B2 (en) 2015-03-13 2018-09-25 Boston Scientific Scimed, Inc. Prosthetic heart valve having an improved tubular seal
US10709555B2 (en) 2015-05-01 2020-07-14 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
WO2016183526A1 (en) 2015-05-14 2016-11-17 Cephea Valve Technologies, Inc. Replacement mitral valves
EP3294220B1 (en) 2015-05-14 2023-12-06 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
WO2017004377A1 (en) 2015-07-02 2017-01-05 Boston Scientific Scimed, Inc. Adjustable nosecone
US10195392B2 (en) 2015-07-02 2019-02-05 Boston Scientific Scimed, Inc. Clip-on catheter
US10179041B2 (en) 2015-08-12 2019-01-15 Boston Scientific Scimed Icn. Pinless release mechanism
US10136991B2 (en) 2015-08-12 2018-11-27 Boston Scientific Scimed Inc. Replacement heart valve implant
US10779940B2 (en) 2015-09-03 2020-09-22 Boston Scientific Scimed, Inc. Medical device handle
US10342660B2 (en) 2016-02-02 2019-07-09 Boston Scientific Inc. Tensioned sheathing aids
US10583005B2 (en) 2016-05-13 2020-03-10 Boston Scientific Scimed, Inc. Medical device handle
EP3454795B1 (en) 2016-05-13 2023-01-11 JenaValve Technology, Inc. Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system
EP3454794B1 (en) 2016-05-13 2021-04-14 St. Jude Medical, Cardiology Division, Inc. Systems for device implantation
US10245136B2 (en) 2016-05-13 2019-04-02 Boston Scientific Scimed Inc. Containment vessel with implant sheathing guide
US11622872B2 (en) 2016-05-16 2023-04-11 Elixir Medical Corporation Uncaging stent
US10201416B2 (en) 2016-05-16 2019-02-12 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
CN113143536B (en) 2016-05-16 2022-08-30 万能医药公司 Opening support
US11331187B2 (en) 2016-06-17 2022-05-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US10076428B2 (en) 2016-08-25 2018-09-18 DePuy Synthes Products, Inc. Expansion ring for a braided stent
US10292851B2 (en) 2016-09-30 2019-05-21 DePuy Synthes Products, Inc. Self-expanding device delivery apparatus with dual function bump
US10182927B2 (en) * 2016-10-21 2019-01-22 DePuy Synthes Products, Inc. Expansion ring for a braided stent
US10231856B2 (en) * 2016-10-27 2019-03-19 Cook Medical Technologies Llc Stent with segments capable of uncoupling during expansion
EP3326691A1 (en) * 2016-11-23 2018-05-30 BIOTRONIK SE & Co. KG Medical implant and systems for intravascular implantation
CR20190381A (en) 2017-01-23 2019-09-27 Cephea Valve Tech Inc Replacement mitral valves
AU2018203053B2 (en) 2017-01-23 2020-03-05 Cephea Valve Technologies, Inc. Replacement mitral valves
CN110392557A (en) 2017-01-27 2019-10-29 耶拿阀门科技股份有限公司 Heart valve simulation
US10905578B2 (en) * 2017-02-02 2021-02-02 C. R. Bard, Inc. Short stent
EP3634311A1 (en) 2017-06-08 2020-04-15 Boston Scientific Scimed, Inc. Heart valve implant commissure support structure
US10842654B2 (en) * 2017-07-19 2020-11-24 Cook Medical Technologies Llc Stent with segments capable of uncoupling during expansion
EP3661458A1 (en) 2017-08-01 2020-06-10 Boston Scientific Scimed, Inc. Medical implant locking mechanism
EP3668449A1 (en) 2017-08-16 2020-06-24 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
JP7055882B2 (en) 2018-01-19 2022-04-18 ボストン サイエンティフィック サイムド,インコーポレイテッド Guidance mode indwelling sensor for transcatheter valve system
WO2019144071A1 (en) 2018-01-19 2019-07-25 Boston Scientific Scimed, Inc. Medical device delivery system with feedback loop
US11147668B2 (en) 2018-02-07 2021-10-19 Boston Scientific Scimed, Inc. Medical device delivery system with alignment feature
US11439732B2 (en) 2018-02-26 2022-09-13 Boston Scientific Scimed, Inc. Embedded radiopaque marker in adaptive seal
US11229517B2 (en) 2018-05-15 2022-01-25 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US11241310B2 (en) 2018-06-13 2022-02-08 Boston Scientific Scimed, Inc. Replacement heart valve delivery device
AU2019204522A1 (en) 2018-07-30 2020-02-13 DePuy Synthes Products, Inc. Systems and methods of manufacturing and using an expansion ring
US10278848B1 (en) 2018-08-06 2019-05-07 DePuy Synthes Products, Inc. Stent delivery with expansion assisting delivery wire
WO2020123486A1 (en) 2018-12-10 2020-06-18 Boston Scientific Scimed, Inc. Medical device delivery system including a resistance member
US11039944B2 (en) 2018-12-27 2021-06-22 DePuy Synthes Products, Inc. Braided stent system with one or more expansion rings
US11439504B2 (en) 2019-05-10 2022-09-13 Boston Scientific Scimed, Inc. Replacement heart valve with improved cusp washout and reduced loading
CN110403732B (en) * 2019-07-04 2022-06-03 李娅娜 A vein ring contracts tectorial membrane support device for myocardial ischemia coronary vein blood vessel
US11554034B2 (en) 2020-10-06 2023-01-17 Venus Medtech (Hangzhou) Inc. Method and assembly for securing an implantable medical device on a delivery system

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445884B (en) 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
EP0140282B2 (en) 1983-10-17 1996-01-10 Showa Denko Kabushiki Kaisha Can-like container and method for manufacturing same
SE453258B (en) 1986-04-21 1988-01-25 Medinvent Sa ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING
US4740207A (en) 1986-09-10 1988-04-26 Kreamer Jeffry W Intralumenal graft
US4950227A (en) 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
CA1329091C (en) 1989-01-31 1994-05-03 Geoffrey S. Martin Catheter with balloon retainer
US5116318A (en) 1989-06-06 1992-05-26 Cordis Corporation Dilatation balloon within an elastic sleeve
US5108416A (en) 1990-02-13 1992-04-28 C. R. Bard, Inc. Stent introducer system
US5387235A (en) * 1991-10-25 1995-02-07 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
JPH07505316A (en) * 1992-03-31 1995-06-15 ボストン サイエンティフィック コーポレーション medical wire
US5409495A (en) 1993-08-24 1995-04-25 Advanced Cardiovascular Systems, Inc. Apparatus for uniformly implanting a stent
US5445646A (en) 1993-10-22 1995-08-29 Scimed Lifesystems, Inc. Single layer hydraulic sheath stent delivery apparatus and method
US5843120A (en) 1994-03-17 1998-12-01 Medinol Ltd. Flexible-expandable stent
US5836965A (en) 1994-10-19 1998-11-17 Jendersee; Brad Stent delivery and deployment method
US6179817B1 (en) * 1995-02-22 2001-01-30 Boston Scientific Corporation Hybrid coating for medical devices
US5556414A (en) * 1995-03-08 1996-09-17 Wayne State University Composite intraluminal graft
US5591197A (en) * 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
US5607442A (en) * 1995-11-13 1997-03-04 Isostent, Inc. Stent with improved radiopacity and appearance characteristics
US5755791A (en) 1996-04-05 1998-05-26 Purdue Research Foundation Perforated submucosal tissue graft constructs
US5944726A (en) 1996-08-23 1999-08-31 Scimed Life Systems, Inc. Stent delivery system having stent securement means
US6077273A (en) 1996-08-23 2000-06-20 Scimed Life Systems, Inc. Catheter support for stent delivery
US5980530A (en) 1996-08-23 1999-11-09 Scimed Life Systems Inc Stent delivery system
US6007543A (en) 1996-08-23 1999-12-28 Scimed Life Systems, Inc. Stent delivery system with stent securement means
US6123712A (en) 1996-08-23 2000-09-26 Scimed Life Systems, Inc. Balloon catheter with stent securement means
US5741327A (en) * 1997-05-06 1998-04-21 Global Therapeutics, Inc. Surgical stent featuring radiopaque markers
CA2310088C (en) 1997-11-14 2008-12-16 Carl E. Yee Multi-sheath delivery catheter
US6132461A (en) 1998-03-27 2000-10-17 Intratherapeutics, Inc. Stent with dual support structure
US6558415B2 (en) 1998-03-27 2003-05-06 Intratherapeutics, Inc. Stent
US6350277B1 (en) 1999-01-15 2002-02-26 Scimed Life Systems, Inc. Stents with temporary retaining bands
US5976155A (en) 1999-03-05 1999-11-02 Advanced Cardiovascular Systems, Inc. System for removably securing a stent on a catheter assembly and method of use
US6183505B1 (en) 1999-03-11 2001-02-06 Medtronic Ave, Inc. Method of stent retention to a delivery catheter balloon-braided retainers
US6258099B1 (en) 1999-03-31 2001-07-10 Scimed Life Systems, Inc. Stent security balloon/balloon catheter
US6478814B2 (en) 1999-06-14 2002-11-12 Scimed Life Systems, Inc. Stent securement sleeves and optional coatings and methods of use
US6673107B1 (en) * 1999-12-06 2004-01-06 Advanced Cardiovascular Systems, Inc. Bifurcated stent and method of making
US6264683B1 (en) 2000-03-17 2001-07-24 Advanced Cardiovascular Systems, Inc. Stent delivery catheter with bumpers for improved retention of balloon expandable stents
US6387118B1 (en) 2000-04-20 2002-05-14 Scimed Life Systems, Inc. Non-crimped stent delivery system
DE10026307A1 (en) 2000-05-26 2001-11-29 Variomed Ag Balzers Stent, positioning element and insertion catheter
US6494906B1 (en) 2000-07-25 2002-12-17 Advanced Cardiovascular Systems, Inc. Stent fold clip
US6554841B1 (en) 2000-09-22 2003-04-29 Scimed Life Systems, Inc. Striped sleeve for stent delivery
EP1326672A4 (en) 2000-10-18 2007-03-07 Nmt Medical Inc Over-the-wire interlock attachment/detachment mechanism
US6623491B2 (en) 2001-01-18 2003-09-23 Ev3 Peripheral, Inc. Stent delivery system with spacer member
EP1365707B2 (en) 2001-02-26 2016-05-11 Covidien LP Implant delivery system with interlock
US6623518B2 (en) 2001-02-26 2003-09-23 Ev3 Peripheral, Inc. Implant delivery system with interlock
US6837901B2 (en) * 2001-04-27 2005-01-04 Intek Technology L.L.C. Methods for delivering, repositioning and/or retrieving self-expanding stents
US6818013B2 (en) * 2001-06-14 2004-11-16 Cordis Corporation Intravascular stent device
US6726714B2 (en) 2001-08-09 2004-04-27 Scimed Life Systems, Inc. Stent delivery system
US20030074044A1 (en) 2001-10-16 2003-04-17 Randby John H. Stent delivery system
US6797001B2 (en) * 2002-03-11 2004-09-28 Cardiac Dimensions, Inc. Device, assembly and method for mitral valve repair

Also Published As

Publication number Publication date
JP4740861B2 (en) 2011-08-03
CA2523259A1 (en) 2004-12-02
EP1631214A1 (en) 2006-03-08
DE602004021593D1 (en) 2009-07-30
US20040236406A1 (en) 2004-11-25
JP2007500567A (en) 2007-01-18
US7235093B2 (en) 2007-06-26
ES2328694T3 (en) 2009-11-17
WO2004103217A1 (en) 2004-12-02
CA2523259C (en) 2012-01-10
ATE433733T1 (en) 2009-07-15

Similar Documents

Publication Publication Date Title
EP1631214B1 (en) Stent delivery system having improved securement means
EP1773247B1 (en) Stent delivery system allowing controlled release of a stent
EP1469794B1 (en) Flared ostial endoprosthesis and delivery system
US5824053A (en) Helical mesh endoprosthesis and methods of use
US6077295A (en) Self-expanding stent delivery system
US6629992B2 (en) Sheath for self-expanding stent
US5976181A (en) Balloon mounted stent and method therefor
US20080015610A1 (en) System for delivering a prosthesis to a luminal os
WO1999048440A1 (en) Helical mesh endoprosthesis and methods of use
CA2457449A1 (en) Hybrid balloon expandable /self-expanding stent
WO2007090128A2 (en) Apparatus and methods for deployment of custom-length prostheses
WO2001041676A1 (en) Detachable covering for an implantable medical device
US20080125845A1 (en) Proximal fixing
US20090093869A1 (en) Medical device with curved struts

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051203

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20070619

RIC1 Information provided on ipc code assigned before grant

Ipc: A61F 2/84 20060101AFI20081030BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 602004021593

Country of ref document: DE

Date of ref document: 20090730

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090617

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090617

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2328694

Country of ref document: ES

Kind code of ref document: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090617

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090917

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090617

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090617

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090617

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090617

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090617

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20091017

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090917

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090617

26N No opposition filed

Effective date: 20100318

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090918

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20100504

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100430

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100430

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100430

BERE Be: lapsed

Owner name: BOSTON SCIENTIFIC LIMITED

Effective date: 20110430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090617

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20091218

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100416

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090617

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20140311

Year of fee payment: 11

REG Reference to a national code

Ref country code: FR

Ref legal event code: CA

Effective date: 20140513

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20140414

Year of fee payment: 11

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602004021593

Country of ref document: DE

Representative=s name: KANZLEI PFENNING, MEINIG & PARTNER GBR, DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602004021593

Country of ref document: DE

Representative=s name: KANZLEI PFENNING, MEINIG & PARTNER GBR, DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602004021593

Country of ref document: DE

Owner name: BOSTON SCIENTIFIC LIMITED, BM

Free format text: FORMER OWNER: BOSTON SCIENTIFIC LTD., BARBADOS, WEST INDIES, BB

Effective date: 20150202

Ref country code: DE

Ref legal event code: R082

Ref document number: 602004021593

Country of ref document: DE

Representative=s name: KANZLEI PFENNING, MEINIG & PARTNER GBR, DE

Effective date: 20140930

Ref country code: DE

Ref legal event code: R082

Ref document number: 602004021593

Country of ref document: DE

Representative=s name: KANZLEI PFENNING, MEINIG & PARTNER GBR, DE

Effective date: 20150202

Ref country code: DE

Ref legal event code: R082

Ref document number: 602004021593

Country of ref document: DE

Representative=s name: PFENNING, MEINIG & PARTNER MBB PATENTANWAELTE, DE

Effective date: 20140930

Ref country code: DE

Ref legal event code: R082

Ref document number: 602004021593

Country of ref document: DE

Representative=s name: PFENNING, MEINIG & PARTNER MBB PATENTANWAELTE, DE

Effective date: 20150202

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602004021593

Country of ref document: DE

Representative=s name: PFENNING, MEINIG & PARTNER MBB PATENTANWAELTE, DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150416

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20160526

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150417

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20190313

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20190412

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20190410

Year of fee payment: 16

Ref country code: DE

Payment date: 20190402

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20190410

Year of fee payment: 16

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602004021593

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20200501

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200430

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201103

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20200416

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200501

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200416

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200416